Keenova Presents New TERLIVAZ® (terlipressin) Data Analyses at Kidney Week 2026
DUBLIN, Oct. 21, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that two presentations on hepatorenal syndrome-acute kidney injury (HRS-AKI) and TERLIVAZ® (terlipressin) will be shared at the American Society of Nephrology (ASN) Kidney Week 2026, taking place October 21-25,...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.